EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development of Best Evidence Dosing Recommendations for Term and Preterm Neonates (NeoDose Project)

Marika A de Hoop-Sommen, Tjitske M van der Zanden, Karel Allegaert, Robert B Flint, Sinno H P Simons, Saskia N de Wildt, Working group Neonatal Pharmacology (NeoDose project)

Neonatology · 2023

DOI: 10.1159/000528012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neonatology, 2023. Verfasst von Marika A de Hoop-Sommen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Pharmaceutical Preparations. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many drugs are used off-label in neonates which leads to large variation in prescribed drugs and dosages in neonatal intensive care units (NICUs). The NeoDose project aimed to develop best evidence dosing recommendations (DRs) for term and preterm neonates using a three-step approach: 1) drug selection, 2) establishing consensus-based DRs, and 3) establishing best evidence DRs.

Methods

The selection of drugs was based on frequency of prescribing, availability of a neonatal DR in the Dutch Pediatric Formulary, and the labeling status. Clinical need, pharmacological diversity, and Working Group Neonatal Pharmacology (WGNP) preferences were also taken into account, using a consensus-based approach. For the second step, we requested local dosing protocols from all ten Dutch NICUs and established consensus-based DRs within the WGNP, consisting of neonatologists, clinical pharmacologists, hospital pharmacists, and researchers. In the third step, the consensus-based DRs were compared with the available literature, using standardized PubMed searches.

Results

Fourteen drugs were selected for which the local dosing protocols were collected. These protocols differed mostly in total daily dose, dosing frequency, and/or route of administration. Strikingly, almost none of the dosing protocols of these 14 drugs distinguished between preterm and term neonates. The working group established consensus-based DRs, which after literature review needed modification in 56%, mainly in terms of a dose increase. Finally, we established 37 best evidence DRs, 22 for preterm and 15 for term neonates, representing 19 indications.

Conclusion

This project showed the successful three-step approach for the development of DRs for term and preterm neonates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pharmaceutical PreparationsHumansInfant, NewbornIntensive Care Units, NeonatalDrug Dosage CalculationsOff-Label UseNetherlands

Stichwörter der Autor:innen

Best evidenceDosing recommendationsPreterm infantTerm infant

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Medicine Information Centre, Royal Dutch Pharmacist Association, The Hague, The Netherlands.
  • Dutch Knowledge Center Pharmacotherapy for Children, The Hague, The Netherlands.
  • Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Zitieren

APA

de Hoop-Sommen, M. A., van der Zanden, T. M., Allegaert, K., Flint, R. B., Simons, S. H. P., de Wildt, S. N., & Working group Neonatal Pharmacology (NeoDose project) (2023). Development of Best Evidence Dosing Recommendations for Term and Preterm Neonates (NeoDose Project). Neonatology. https://doi.org/10.1159/000528012

Vancouver

de Hoop-Sommen MA, van der Zanden TM, Allegaert K, Flint RB, Simons SHP, de Wildt SN, et al. Development of Best Evidence Dosing Recommendations for Term and Preterm Neonates (NeoDose Project). Neonatology. 2023. doi:10.1159/000528012

BibTeX
@article{deHoopSommen2023,
  author = {de Hoop-Sommen, Marika A and van der Zanden, Tjitske M and Allegaert, Karel and Flint, Robert B and Simons, Sinno H P and de Wildt, Saskia N and Working group Neonatal Pharmacology (NeoDose project), Working group Neonatal Pharmacology (NeoDose project)},
  title = {Development of Best Evidence Dosing Recommendations for Term and Preterm Neonates (NeoDose Project)},
  journal = {Neonatology},
  year = {2023},
  doi = {10.1159/000528012}
}
Kostenlos starten →